Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008

Journal of Forensic Sciences

Volumn 55, Issue 5, 2010, Pages 1209-1217

  Mehmedic, Zlatko ^a   Chandra, Suman ^a   Slade, Desmond ^a   Denham, Heather ^a   Foster, Susan ^a   Patel, Amit S ^b,c   Ross, Samir A ^a,b   Khan, Ikhlas A ^a,b   ElSohly, Mahmoud A ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c Medical Marketing Economics LLC   (United States)

Author keywords

9 tetrahydrocannabinol ( 9 THC); cannabichromene (CBC); cannabidiol (CBD); cannabigerol (CBG); cannabinoids; cannabinol (CBN); cannabis; criminalistics; forensic science; gas chromatography flame ionization detection (GC FID); marijuana; potency; tetrahydrocannabivarin (THCV)

Indexed keywords

CANNABINOID; CANNABIS; STREET DRUG; TETRAHYDROCANNABINOL; VEGETABLE OIL;

ARTICLE; CHEMISTRY; GAS CHROMATOGRAPHY;

CANNABINOIDS; CANNABIS; FLAME IONIZATION; PLANT OILS; STREET DRUGS; TETRAHYDROCANNABINOL;

EID: 77952314867     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2010.01441.x     Document Type: Article

References (43)

1. Leggett T. A review of the world cannabis situation. United Nations Office On Drugs and Crime (UNODC). Bull Narc 2006 58 : 1 155.
2. UNODC World Drug Report 2008, http://www.unodc.org/documents/wdr/WDR- 2008/WDR-2008-eng-web.pdf (accessed April 14, 2009).
3. Pacifico D, Miselli F, Micheler M, Carboni A, Ranalli P, Mandolino G. Genetics and marker-assisted selection of the chemotype in Cannabis sativa L. Mol Breed 2006 17 : 257 268.
4. Pacifico D, Miselli F, Carboni A, Moschella A, Mandolino G. Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L. Euphytica 2008 160 : 231 240.
5. Bócsa I, Máthé P, Hangyel L. Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L.) leaves at different positions. J Int Hemp Assoc 1997 4 : 78 9.
6. Lewis R, Ward S, Johnson R, Burns DT. Distribution of the principal cannabinoids within bars of compressed cannabis resin. Anal Chim Acta 2005 538 : 399 405.
7. ElSohly MA, Slade D. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 2005 78 : 539 548.
8. Appendino G, Giana A, Gibbons S, Maffei M, Gnavi G, Grassi G, et al. A polar cannabinoid from Cannabis sativa var. Carma. Nat Prod Commun 2008 3 : 1977 1980.
9. Radwan MM, ElSohly MA, Slade D, Ahmed SA, Wilson L, El-Alfy AT, et al. Non-cannabinoid constituents from a high potency Cannabis sativa variety. Phytochemistry 2008 69 : 2627 2633.
10. Ahmed SA, Ross SA, Slade D, Radwan MM, Khan IA, ElSohly MA. Structure determination and absolute configuration of cannabichromanone derivatives from high potency Cannabis sativa. Tetrahedron Lett 2008 49 : 6050 6053.
11. Radwan MM, Ross SA, Slade D, Ahmed SA, Zulfiqar F, ElSohly MA. Isolation and characterization of new cannabis constituents from a high potency variety. Planta Med 2008 74 : 267 272.
12. Ahmed SA, Ross SA, Slade D, Radwan MM, Zulfiqar F, ElSohly MA. Cannabinoid ester constituents from high-potency Cannabis sativa. J Nat Prod 2008 71 : 536 542.
13. Radwan MM, ElSohly MA, Slade D, Ahmed SA, Khan IA, Ross SA. Biologically active cannabinoids from high potency Cannabis sativa. J Nat Prod 2009 72 : 906 911.
14. Mackie K. Understanding cannabinoid psychoactivity with mouse genetic models. PLoS Biol 2007 5 : 2106 2108.
15. Mackie K. From active ingredients to the discovery of the targets: the cannabinoid receptors. Chem Biodiversity 2007 4 : 1693 1706.
16. Galal AM, Slade D, Gul W, El-Alfy AT, Ferreira D, ElSohly MA. Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications. Recent Pat CNS Drug Discovery 2009 4 : 112 136.
17. 9-tetrahydrocannabivarin. Br J Pharmacol 2008 153 : 199 215.
18. Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO. Cannabidiol - recent advances. Chem Biodiversity 2007 4 : 1678 1692.
19. Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 2006 31 : 2296 2303.
20. Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr (Braz J Psychiatry) 2006 28 : 153 157.
21. McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction 2008 103 : 1100 1109.
22. Smith N. High potency cannabis: the forgotten variable. Addiction 2005 100 : 1558 1560.
23. Carter GT, Mirken B. Medical marijuana: politics trumps science at the FDA. MedGenMed 2006 8 : 46.
24. Swami M. Cannabis and cancer link. Nat Rev Cancer 2009 9 : 148.
25. 9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J Forensic Sci 2000 45 : 24 30.
26. th ACS National Meeting, Book of Abstracts 2000 TOXI:006.
27. 9-tetrahydrocannabinol content of confiscated marijuana, 1974-1983. In : Harvey DJ, Paton W, Nahas GG, editors. Marijuana '84: proceedings of the Oxford symposium on cannabis. England : IRL Press, 1985 37 42.
28. ElSohly MA, Holley JH, Lewis GS, Russell MH, Turner CE. Constituents of Cannabis sativa L. XXIV: the potency of confiscated marijuana, hashish, and hash oil over a ten-year period. J Forensic Sci 1984 29 : 500 514.
29. 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 2008 53 : 90 4.
30. Lopes de Oliveira G, Voloch MH, Sztulman GB, Negrini Neto O, Yonamine M. Cannabinoid contents in cannabis products seized in São Paulo, Brazil, 2006-2007. Forensic Toxicol 2008 26 : 31 5.
31. 9-THC in cannabis preparations sold in Dutch coffee shops. Addict Biol 2005 10 : 171 180.
32. King LA, Carpentier C, Griffiths P. An overview of cannabis potency in Europe. Luxembourg, Belgium. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2004. http://www.emcdda.europa.eu/attachements.cfm/att-33985- EN-Insight6.pdf (accessed April 18, 2009).
33. van Laar M, Cruts G, van Gageldonk A, Croes E, van Ooyen-Houben M, Meijer R, et al. The Netherlands drug situation 2007: report to the EMCDDA by the reitox national focal point. Utrecht, Netherlands. Trimbos Institute, Netherlands Institute of Mental Health and Addiction, 2008, http://english.wodc. nl/images/The%20Netherlands%20Drug%20Situation%202007-tcm45-115793.pdf (accessed April 18, 2009).
34. Niesink RJM, Rigter S, Hoek J, Goldschmidt H. THC concentrations in marijuana, nederwiet and hash in Netherlands coffee shops (2006-2007). Utrecht, The Netherlands : Trimbos Institute, Netherlands Institute of Mental Health and Addiction, 2007.
35. 9-THC content in illicit cannabis products over the period 1997-2004 (first four months). Ann Ist Super Sanità 2005 41 : 483 485.
36. Poulsen HA, Sutherland GJ. The potency of cannabis in New Zealand from 1976 to 1996. Sci Justice 2000 40 : 171 176.
37. Hall W, Swift W. The THC content of cannabis in Australia: evidence and implications. Aust NZ J Public Health 2000 24 : 503 508.
38. 9-Tetrahydrocannabinol content of commercially available hemp products. J Anal Toxicol 2008 32 : 428 432.
39. King LA, Carpentier C, Griffiths P. Cannabis potency in Europe. Addiction 2005 100 : 884 886.
40. Barnett V, Lewis T. Outliers in statistical data, 3rd edn. New York, NY : John Wiley & Sons Ltd., 1994.
41. 9-THC concentration ratio as an indicator of the age of stored marijuana samples. Bull Narc 1997-1998 49-50 : 139 147.
42. 9- Tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. J Anal Toxicol 2001 25 : 565 571.
43. 9-THCV) as a marker for the ingestion of cannabis versus Marinol. J Anal Toxicol 1999 23 : 222 224.